vTv Therapeutics (VTVT) Gains from Investment Securities (2023 - 2026)
vTv Therapeutics' (VTVT) quarterly Gains from Investment Securities came in at -$35000.0 in Q2 2026, up 35.19% year-over-year from -$25890.4 in Q2 2025, and down 45.83% quarter-over-quarter from -$24000.0 in Q1 2026.
Powered by 
Analysis
vTv Therapeutics (VTVT) Gains from Investment Securities (2023 - 2026) Analysis & Trends
vTv Therapeutics has disclosed Gains from Investment Securities across 4 years of filings, most recently posting -$35000.0 for Q2 2026.
- In Q2 2026, Gains from Investment Securities rose 35.19% year-over-year to -$35000.0; the TTM figure through Jun 2026 stood at $76000.0 (up 117.43% YoY), while the FY2025 annual figure was $109000.0, up 168.12% from the prior year.
- Gains from Investment Securities came in at -$35000.0 for Q2 2026 at vTv Therapeutics, down from -$24000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $371000.0 in Q1 2024 to a low of -$341000.0 in Q3 2023.
- Average Gains from Investment Securities over 4 years is -$51583.3, with a median of -$44500.0 recorded in 2025.
- Year-over-year, Gains from Investment Securities surged 184.42% in 2025 and sank 185.71% in 2026.
- Over 4 years, Gains from Investment Securities stood at -$168000.0 in 2023, then slumped by 98.21% to -$333000.0 in 2024, then surged by 121.02% to $70000.0 in 2025, then plunged by 150.0% to -$35000.0 in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$35000.0 in Q2 2026, -$24000.0 in Q1 2026, and $70000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35,000.00 |
| Mar 31, 2026 | -24,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | -54,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | -333,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -121,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | -168,000.00 |
| Sep 30, 2023 | -341,000.00 |